Illumina Management
Management criteria checks 2/4
Illumina's CEO is Jacob Thaysen, appointed in Sep 2023, has a tenure of less than a year. total yearly compensation is $4.69M, comprised of 5.3% salary and 94.7% bonuses, including company stock and options. directly owns 0.005% of the company’s shares, worth $854.11K. The average tenure of the management team and the board of directors is 1.1 years and 5.2 years respectively.
Key information
Jacob Thaysen
Chief executive officer
US$4.7m
Total compensation
| CEO salary percentage | 5.3% |
| CEO tenure | less than a year |
| CEO ownership | 0.005% |
| Management average tenure | 1.1yrs |
| Board average tenure | 5.2yrs |
Recent management updates
Recent updates
Revenues Not Telling The Story For Illumina, Inc. (NASDAQ:ILMN)
Mar 20
Illumina: Stagnant Revenues And Shrinking Margins Amidst Rising Competition
Feb 23Would Illumina (NASDAQ:ILMN) Be Better Off With Less Debt?
Jan 26Illumina: Volatility Galore, But Not Much Prospect Of Progress In 2024
Jan 19Investors Appear Satisfied With Illumina, Inc.'s (NASDAQ:ILMN) Prospects As Shares Rocket 40%
Dec 21Is Illumina, Inc. (NASDAQ:ILMN) Potentially Undervalued?
Dec 03Would Illumina (NASDAQ:ILMN) Be Better Off With Less Debt?
Oct 24Is There An Opportunity With Illumina, Inc.'s (NASDAQ:ILMN) 40% Undervaluation?
Oct 03At US$167, Is Illumina, Inc. (NASDAQ:ILMN) Worth Looking At Closely?
Aug 22The Big Trends: New Frontiers in Healthcare
Jul 13
Estimating The Intrinsic Value Of Illumina, Inc. (NASDAQ:ILMN)
Jul 03Illumina (NASDAQ:ILMN) Is Carrying A Fair Bit Of Debt
Jun 13Is It Time To Consider Buying Illumina, Inc. (NASDAQ:ILMN)?
Apr 12Is Illumina (NASDAQ:ILMN) Using Too Much Debt?
Mar 14Are Investors Undervaluing Illumina, Inc. (NASDAQ:ILMN) By 38%?
Dec 30Should You Investigate Illumina, Inc. (NASDAQ:ILMN) At US$221?
Dec 02These 4 Measures Indicate That Illumina (NASDAQ:ILMN) Is Using Debt Reasonably Well
Oct 27Illumina, GenoScreen collaborate on genomic testing for drug-resistant TB
Oct 18Illumina in research collaboration with AstraZeneca on drug target discovery
Oct 11Illumina Engages Obama To Push Its Customers' Reimbursement Agenda
Sep 29Illumina to appeal EU decision to block GRAIL acquisition
Sep 06Illumina Needs Grail, But May Lose It
Aug 30Illumina added to positive catalyst watch at Citi despite Q2 miss
Aug 22Illumina up 9% following drop after Q2 earnings
Aug 15Is It Too Late To Consider Buying Illumina, Inc. (NASDAQ:ILMN)?
Aug 08Still Avoiding Illumina Stock
Aug 05Illumina, Grail deal unlikely to get EU nod – Reuters
Jul 27Is Illumina, Inc. (NASDAQ:ILMN) Trading At A 48% Discount?
Jul 22Ensemble Capital Management - Illumina: Never Been So Cheap
Jul 19CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$5m | US$250k | -US$1b |
Compensation vs Market: Jacob's total compensation ($USD4.69M) is below average for companies of similar size in the US market ($USD13.41M).
Compensation vs Earnings: Insufficient data to compare Jacob's compensation with company performance.
CEO
Jacob Thaysen (48 yo)
less than a year
Tenure
US$4,691,233
Compensation
Mr. Jacob Thaysen, Ph.D. serves as Chief Executive Officer at Illumina, Inc. since September 25, 2023 and serves as its Director since September 2023. Mr. Thaysen joined the Illumina, Inc. in September 202...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | less than a year | US$4.69m | 0.0046% $ 854.1k | |
| Chief Information Officer | 2.1yrs | US$2.93m | 0.0011% $ 200.5k | |
| Senior VP & General Counsel | 11yrs | US$4.10m | 0.0057% $ 1.1m | |
| Advisor | no data | US$5.31m | 0.0063% $ 1.2m | |
| President | no data | no data | no data | |
| Chief Financial Officer | no data | no data | no data | |
| Chief of Global Operations | 2.4yrs | no data | 0.011% $ 2.0m | |
| VP & Chief Accounting Officer | 1.5yrs | no data | 0.0067% $ 1.2m | |
| Chief Technology Officer | less than a year | no data | 0.017% $ 3.2m | |
| Vice President of Investor Relations | 3.3yrs | no data | no data | |
| Chief Strategy & Corporate Development Officer and CEO Chief of Staff | no data | no data | no data | |
| Senior VP & Chief People Officer | less than a year | no data | 0.0055% $ 1.0m |
1.1yrs
Average Tenure
52.5yo
Average Age
Experienced Management: ILMN's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | less than a year | US$4.69m | 0.0046% $ 854.1k | |
| Independent Director | 7.3yrs | US$408.88k | 0.00089% $ 165.3k | |
| Independent Director | 5.2yrs | US$398.58k | 0.0041% $ 755.7k | |
| Independent Chairman of the Board | less than a year | US$388.22k | no data | |
| Independent Director | 7.8yrs | US$395.10k | 0.0076% $ 1.4m | |
| Independent Director | 11.4yrs | US$405.10k | 0.0093% $ 1.7m | |
| Independent Director | 6.3yrs | US$404.29k | 0.0053% $ 984.1k | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | 8.3yrs | US$400.10k | 0.0082% $ 1.5m | |
| Independent Director | 4.2yrs | US$391.37k | 0.0025% $ 469.8k | |
| Independent Director | less than a year | US$343.87k | no data | |
| Member of Ethics Advisory Board | no data | no data | no data |
5.2yrs
Average Tenure
59yo
Average Age
Experienced Board: ILMN's board of directors are considered experienced (5.2 years average tenure).